Novel immunotherapeutics against LGR5 to target multiple cancer types (vol 16, pg 2233, 2024)

被引：1
|
作者：
Chen, Hung-Chang
Mueller, Nico
Stott, Katherine
Kapeni, Chrysa
Rivers, Eilidh
Sauer, Carolin M.
Beke, Flavio
Walsh, Stephen J.
Ashman, Nicola
O'Brien, Louise
Fard, Amir Rafati
Ghodsinia, Arman
Li, Changtai
Joud, Fadwa
Giger, Olivier
Zlobec, Inti
Olan, Ioana
Aitken, Sarah J.
Hoare, Matthew
Mair, Richard
Serrao, Eva
Brenton, James D.
Garcia-Gimenez, Alicia
Richardson, Simon E.
Huntly, Brian
Spring, David R.
Skjoedt, Mikkel-Ole
Skjodt, Karsten
de la Roche, Marc
de la Roche, Maike
机构：
[1] Cancer Research UK Cambridge Institute,University of Cambridge
[2] Department of Biochemistry,University of Cambridge
[3] Yusuf Hamied Department of Chemistry,University of Cambridge
[4] Department of Pathology,University of Cambridge
[5] University of Bern,Institute of Pathology
[6] MRC Toxicology Unit,University of Cambridge
[7] Cambridge University Hospitals,Department of Histopathology
[8] NHS Foundation Trust,University of Cambridge
[9] Department of Haematology,Institute of Immunology and Microbiology
[10] Rigshospitalet—University Hospital Copenhagen,undefined
[11] University of Copenhagen,undefined
[12] Blegdamsvej 3B,undefined
[13] University of Southern Denmark Campusvej 55,undefined
[14] Astra Zeneca,undefined
[15] MRC-University of Glasgow Centre for Virus Research,undefined
[16] Bicycle Therapeutics,undefined
[17] Charles River Laboratories,undefined
[18] Novo Nordisk,undefined
来源：
EMBO MOLECULAR MEDICINE | 2024年 / 16卷 / 11期
关键词：
D O I：
10.1038/s44321-024-00139-6
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
[graphic not available: see fulltext]
引用
收藏
页码：3026 / 3026
页数：1
相关论文
共 11 条
  • [1] Novel immunotherapeutics against LGR5 to target multiple cancer types
    Chen, Hung-Chang
    Mueller, Nico
    Stott, Katherine
    Kapeni, Chrysa
    Rivers, Eilidh
    Sauer, Carolin M.
    Beke, Flavio
    Walsh, Stephen J.
    Ashman, Nicola
    O'Brien, Louise
    Rafati Fard, Amir
    Godsinia, Arman
    Li, Changtai
    Joud, Fadwa
    Giger, Olivier
    Zlobec, Inti
    Olan, Ioana
    Aitken, Sarah J.
    Hoare, Matthew
    Mair, Richard
    Serrao, Eva
    Brenton, James D.
    Garcia-Gimenez, Alicia
    Richardson, Simon E.
    Huntly, Brian
    Spring, David R.
    Skjoedt, Mikkel-Ole
    Skjodt, Karsten
    de la Roche, Marc
    de la Roche, Maike
    EMBO MOLECULAR MEDICINE, 2024, 16 (10) : 2583 - 2618
  • [2] Increased expression of Lgr5 is associated with chemotherapy resistance in human gastric cancer (vol 32, pg 181, 2014)
    Xi, Hong-Qing
    Cui, Jian-Xin
    Shen, Wei-Song
    Wu, Xiao-Song
    Bian, Shi-Bo
    Li, Ji-Yang
    Song, Zhou
    Wei, Bo
    Chen, Lin
    ONCOLOGY REPORTS, 2019, 42 (01) : 462 - 462
  • [3] LGR5 CAR-T cells: A novel potential treatment against high grade serous ovarian cancer.
    Wang, Wanqi
    Bandara, Veronika
    Lokman, Noor
    Napoli, Silvana
    Gundsambuu, Batjargal
    Oehler, Martin
    Barry, Simon C.
    Ricciardelli, Carmela
    CANCER RESEARCH, 2022, 82 (12)
  • [4] GPRC5D as a novel target for the treatment of multiple myeloma: a narrative review (vol 14, 24, 2024)
    Rodriguez-Otero, Paula
    van de Donk, Niels W. C. J.
    Pillarisetti, Kodandaram
    Cornax, Ingrid
    Vishwamitra, Deeksha
    Gray, Kathleen
    Hilder, Brandi
    Tolbert, Jaszianne
    Renaud, Thomas
    Masterson, Tara
    Heuck, Christoph
    Kane, Colleen
    Verona, Raluca
    Moreau, Philippe
    Bahlis, Nizar
    Chari, Ajai
    BLOOD CANCER JOURNAL, 2024, 14 (01)
  • [5] CD151 promotes Colorectal Cancer progression by a crosstalk involving CEACAM6, LGR5 and Wnt signaling via TGFβ1 (vol 17, pg 848, 2021)
    Yang, Tao
    Wang, Huibing
    Li, Meng
    Yang, Linqi
    Han, Yu
    Liu, Chao
    Zhang, Baowen
    Wu, Mingfa
    Wang, Gang
    Zhang, Zhenya
    Zhang, Wenqi
    Huang, Jianming
    Zhang, Huaxing
    Cao, Ting
    Chen, Pingping
    Zhang, Wei
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2023, 19 (10): : 3290 - 3291
  • [6] Synthesis and SAR of novel capsazepine analogs with significant anti-cancer effects in multiple cancer types (vol 27, pg 208, 2019)
    De La Chapa, Jorge
    Valdez, Matthew
    Ruiz, Francisco, II
    Gonzales, Keith
    Mitchell, Wes
    McHardy, Stanton F.
    Hart, Matthew J.
    Polusani, Srikanth R.
    Gonzales, Cara B.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2019, 27 (11) : 2280 - 2280
  • [7] COTI-2, a novel small molecule that is active against multiple human cancer cell lines in vitro and in vivo (vol 7, pg 41363, 2016)
    Salim, Kowthar Y.
    Vareki, Saman Maleki
    Danter, Wayne R.
    Koropatnick, Serban San-Marina James
    ONCOTARGET, 2017, 8 (36) : 60724 - 60724
  • [8] METTL5 promotes cell proliferation, invasion, and migration by up-regulating Toll-like receptor 8 expression in colorectal cancer (vol 16, pg 2006, 2024)
    Kong, Ling-Shang
    Tao, Ran
    Li, Yi-Fan
    Wang, Wen-Bin
    Zhao, Xue
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2025, 17 (02)
  • [9] PinX1, a novel target gene of p53, is suppressed by HPV16 E6 in cervical cancer cells (vol 1839, pg 88, 2014)
    Wu, Gengze
    Liu, Dongbo
    Jiang, Ke
    Zhang, Li
    Zeng, Yijun
    Zhou, Peng
    Zhong, Dan
    Gao, Min
    He, Fengtian
    Zheng, Yingru
    BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS, 2015, 1849 (03): : 367 - 367
  • [10] RETRACTION: Retraction of BIRC5 is a novel target of peroxisome proliferator-activated receptor γ in brain microvascular endothelium cells during cerebral ischemia (Retraction of Vol 16, Pg 8882, 2017)
    Xu, Mingjing
    Yang, Xianli
    Zeng, Qing
    He, He
    Lu, Pengcheng
    Huang, Guozhi
    MOLECULAR MEDICINE REPORTS, 2018, 18 (05) : 4767 - 4767
12